Organization:Chinese Academy of Medical Sciences COVID-19 vaccine
From HandWiki
Short description: Vaccine against COVID-19
| Vaccine description | |
|---|---|
| Target disease | SARS-CoV-2 |
| Type | Killed/Inactivated |
| Clinical data | |
| Other names | Covidful (Chinese: 科维福; pinyin: Kēwéifú) |
| Routes of administration | Intramuscular |
| Legal status | |
| Legal status |
|
| Identifiers | |
| DrugBank | |
Chinese Academy of Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: 科维福; pinyin: Kēwéifú), is a COVID-19 vaccine developed by Institute of Medical Biology, Chinese Academy of Medical Sciences (zh).
Clinical trials
In May 2020, Covidful started phase I/II clinical trial with 942 participants in China.[2]
In January 2021, Covidful started phase III clinical trials with 34,020 from Brazil and Malaysia.[3]
Authorizations
<graph>{"version":2,"height":1,"marks":[{"type":"path","properties":{"enter":{"path":{"field":"layout_path"}},"update":{"fill":{"field":"zipped.v"}},"hover":{"fill":{"value":"darkgrey"}}},"from":{"data":"countries"}}],"data":[{"name":"highlights","values":[{"id":"CN","v":"dodgerblue"},{"id":"HK","v":"turquoise"},{"id":"NZ","v":"turquoise"}]},{"transform":[{"type":"geopath","translate":[0,0],"value":"data","projection":"equirectangular","scale":50},{"onKey":"id","type":"lookup","default":{"v":"gainsboro"},"keys":["id"],"on":"highlights","as":["zipped"]}],"url":"wikiraw:///Template%3AGraph%3AMap%2FInner%2FWorldmap2c-json","name":"countries","format":{"feature":"countries","type":"topojson"}}],"width":1}</graph>
Full authorization
Emergency authorization
Allowed for travel
On 9 June 2021, The vaccine has been approved by the Chinese authorities.[1]
References
- ↑ 1.0 1.1 "China builds new plant for IMBCAMS COVID-19 vaccine -state media". Reuters. 9 June 2021. https://www.reuters.com/world/asia-pacific/china-builds-new-plant-imbcams-covid-19-vaccine-state-media-2021-06-09/.
- ↑ Clinical trial number NCT04412538 for "Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19" at ClinicalTrials.gov
- ↑ Clinical trial number NCT04659239 for "The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19" at ClinicalTrials.gov
External links
 |
